ICM - Instituto do Coração de Marília
Marilia, Brazil
Cardiologist in São Paulo
Av. Vicente Ferreira, 780 - Cascata, Marília - SP, 17515-000
About ICM - Instituto do Coração de Marília
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at ICM - Instituto do Coração de Marília
During the past decade, ICM - Instituto do Coração de Marília conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on
average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
2017-07-11
2021-03-12
Completed
143
A Long Term Study to Find Out if Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
2018-12-07
2021-10-12
Terminated
91
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
2019-06-11
2025-07-26
Active, not recruiting
12,301
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
2020-09-14
2024-09-13
Active, not recruiting
6,016
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
2022-10-11
2027-10-07
Recruiting
15,000
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "ICM - Instituto do Coração de Marília" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Actelion" with 2 trials
sponsored, "Bayer" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Eli Lilly and Company"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "ICM - Instituto do Coração de Marília"
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "AcitGraph" with 1 trials as a collaborator, "Almac Clinical Technologies, LLC" with 1 trials as a collaborator, "Chiltern International Ltd." with 1 trials as a collaborator and "Covance Central Laboratory Services, LP" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at ICM - Instituto do Coração de Marília
According to Clinical.Site data, the most researched conditions in "ICM - Instituto do Coração de Marília" are
"Heart Failure" (3 trials), "Atrial Fibrillation" (1 trials), "Coronary Heart Disease (CHD)" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Heart Failure With Preserved Ejection Fraction" (1 trials). Many other conditions were trialed in "ICM - Instituto do Coração de Marília" in a lesser frequency.
Clinical Trials Intervention Types at ICM - Instituto do Coração de Marília
Most popular intervention types in "ICM - Instituto do Coração de Marília" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Empagliflozin" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at ICM - Instituto do Coração de Marília
The vast majority of trials in "ICM - Instituto do Coração de Marília" are
9 trials for "All" genders.
Clinical Trials Status at ICM - Instituto do Coração de Marília
Currently, there are NaN active trials in "ICM - Instituto do Coração de Marília".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in ICM - Instituto do Coração de Marília,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in ICM - Instituto do Coração de Marília, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".